Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Gossamer Bio (GOSS) EPS (Weighted Average and Diluted) (2022 - 2025)

Gossamer Bio's EPS (Weighted Average and Diluted) history spans 4 years, with the latest figure at -$0.21 for Q4 2025.

  • For Q4 2025, EPS (Weighted Average and Diluted) fell 40.0% year-over-year to -$0.21; the TTM value through Dec 2025 reached -$0.75, down 188.46%, while the annual FY2025 figure was -$0.75, 200.0% down from the prior year.
  • EPS (Weighted Average and Diluted) reached -$0.21 in Q4 2025 per GOSS's latest filing, roughly flat from -$0.21 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.22 in Q2 2024 to a low of -$0.76 in Q1 2022.
  • Average EPS (Weighted Average and Diluted) over 4 years is -$0.32, with a median of -$0.21 recorded in 2025.
  • Peak YoY movement for EPS (Weighted Average and Diluted): skyrocketed 148.89% in 2024, then crashed 177.27% in 2025.
  • A 4-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.57 in 2022, then skyrocketed by 73.68% to -$0.15 in 2023, then dropped by 0.0% to -$0.15 in 2024, then crashed by 40.0% to -$0.21 in 2025.
  • Per Business Quant, the three most recent readings for GOSS's EPS (Weighted Average and Diluted) are -$0.21 (Q4 2025), -$0.21 (Q3 2025), and -$0.17 (Q2 2025).